Joana Ribeiro da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joana Ribeiro da Silva has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
João Carvalho
Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
4 shared publications- Rolando Pinho
Department of Gastroenterology, Unidade Local de Saúde Gaia e Espinho, 4430-502 Vila Nova de Gaia, Portugal
4 shared publications Ana Ponte
Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
3 shared publicationsAdélia Rodrigues
Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
2 shared publicationsJaime Rodrigues
Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
2 shared publicationsMafalda Sousa
Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
2 shared publications
Latest Publications
- Open Access
- 17 January 2018
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
- Vol. 25 (5) , 222-229
Evaluation of the Usefulness of Virtual Chromoendoscopy with Different Color Modes in the MiroCam® System for Characterization of Small Bowel Lesions
Background: Virtual chromoendoscopy (VC) in small bowel capsule endoscopy can improve the visualization and characterization of different small bowel lesions (SBLs). There are few studies of its usefulness in the Given® system, and there is no evidence yet of its utility in the MiroCam® system. Aim: The aim of this study was to evaluate whether VC can improve the characterization of SBLs with the MiroCam® system. Methods: Twenty-two patients were selected, in which 100 elementary lesions were identified, including erosions (n = 45), ulcers (n = 17), and angioectasias (n = 38). For each lesion identified, images were captured without chromoendoscopy (normal image [NI]) and with chromoendoscopy modes 1 (color mode [CM] 1), 2 (CM2), and 3 (CM3). A score from 1 to 4 was assigned to each image, in which a better evaluation of the characteristics and limits of the lesion was classified in ascending order, where 1 is the worst and 4 the best evaluation. The scores of the various modes were compared with Kendall's tau-c coefficient. Results: The average scores attributed to the photographs in NI, CM1, CM2, and CM3 were 3.83, 2.89, 1.85, and 1.43, respectively (tau-c = -0.75, p < 0.001). Evaluating the elementary lesions independently, the average scores for modes NI, CM1, CM2, and CM3 were 3.83, 2.92, 1.86, and 1.38 (tau-c = -0.77, p < 0.001) for erosions, respectively; 3.87, 2.96, 1.76, and 1.40 (tau-c = -0.80, p < 0.001) for ulcers, respectively; and 3.81, 2.82, 1.87, and 1.50 (tau-c = -0.71, p < 0.001) for angioectasias, respectively. Conclusions: VC using the CMs available in the MiroCam® system has not proven useful for a better assessment of any of the SBLs.
- 17 January 2018
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
- Vol. 25 (5) , 222-229
Open AccessEvaluation of the Usefulness of Virtual Chromoendoscopy with Different Color Modes in the MiroCam® System for Characterization of Small Bowel Lesions
Background: Virtual chromoendoscopy (VC) in small bowel capsule endoscopy can improve the visualization and characterization of different small bowel lesions (SBLs). There are few studies of its usefulness in the Given® system, and there is no evidence yet of its utility in the MiroCam® system. Aim: The aim of this study was to evaluate whether VC can improve the characterization of SBLs with the MiroCam® system. Methods: Twenty-two patients were selected, in which 100 elementary lesions were identified, including erosions (n = 45), ulcers (n = 17), and angioectasias (n = 38). For each lesion identified, images were captured without chromoendoscopy (normal image [NI]) and with chromoendoscopy modes 1 (color mode [CM] 1), 2 (CM2), and 3 (CM3). A score from 1 to 4 was assigned to each image, in which a better evaluation of the characteristics and limits of the lesion was classified in ascending order, where 1 is the worst and 4 the best evaluation. The scores of the various modes were compared with Kendall's tau-c coefficient. Results: The average scores attributed to the photographs in NI, CM1, CM2, and CM3 were 3.83, 2.89, 1.85, and 1.43, respectively (tau-c = -0.75, p < 0.001). Evaluating the elementary lesions independently, the average scores for modes NI, CM1, CM2, and CM3 were 3.83, 2.92, 1.86, and 1.38 (tau-c = -0.77, p < 0.001) for erosions, respectively; 3.87, 2.96, 1.76, and 1.40 (tau-c = -0.80, p < 0.001) for ulcers, respectively; and 3.81, 2.82, 1.87, and 1.50 (tau-c = -0.71, p < 0.001) for angioectasias, respectively. Conclusions: VC using the CMs available in the MiroCam® system has not proven useful for a better assessment of any of the SBLs.
- Open Access
- 21 December 2017
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
- Vol. 25 (5) , 236-242
Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy
Background: Obesity is an increasing worldwide problem associated with a vast number of comorbidities. Decreasing body weight by only 5-10% has been shown to slow and even prevent the onset of obesity-related comorbidities. Between pharmacological therapy and bariatric surgery a great variety of endoscopic techniques are available, the most common being intragastric balloon (IGB). The purpose of this study was to assess the safety, tolerance, and kinetics of IGBs in weight loss. The kinetics of weight loss were evaluated in 2 different contexts and phases: after the IGB's removal and after follow-up that varied between 6 and 12 months. Successful weight loss was defined as ≥10% weight loss after 6-12 months. Methods: The study included 51 patients who had undergone Orbera® IGB placement between September 2014 and February 2016. Inclusion criteria were age between 18 and 65 years; body mass index (BMI) 28-35 with severe obesity-related disorders; or BMI 35-40. The IGB was removed 6 months later. All patients were followed for a minimum period of 6-12 months. Results: Of 51 patients, 16 were excluded (7 due to intolerance) and 35 patients entered the study, of which 83% were followed for more than 6-12 months. The average weight loss (WL) and % excess WL (%EWL) after 6 months of treatment were 11.94 kg and 42.16%, respectively. At 6-12 months, after removal of the IGB, the mean WL was 8.25 kg and %EWL was 30.27%. Nineteen patients attained a WL of ≥10% the baseline value at IGB removal and 12 maintained their weight below this threshold during the 6-12 following months. Conclusions: After temporary IGB implantation in overweight or obese individuals, a WL that was ≥10% of weight at baseline was achieved in 54.3% and sustained at 6-12 months in 41.4% of participants. IGBs are an attractive intermediate option between diet and exercise programs and bariatric surgery. In general, IGB placement is a safe and well-tolerated procedure.
- 21 December 2017
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
- Vol. 25 (5) , 236-242
Open AccessIntragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy
Background: Obesity is an increasing worldwide problem associated with a vast number of comorbidities. Decreasing body weight by only 5-10% has been shown to slow and even prevent the onset of obesity-related comorbidities. Between pharmacological therapy and bariatric surgery a great variety of endoscopic techniques are available, the most common being intragastric balloon (IGB). The purpose of this study was to assess the safety, tolerance, and kinetics of IGBs in weight loss. The kinetics of weight loss were evaluated in 2 different contexts and phases: after the IGB's removal and after follow-up that varied between 6 and 12 months. Successful weight loss was defined as ≥10% weight loss after 6-12 months. Methods: The study included 51 patients who had undergone Orbera® IGB placement between September 2014 and February 2016. Inclusion criteria were age between 18 and 65 years; body mass index (BMI) 28-35 with severe obesity-related disorders; or BMI 35-40. The IGB was removed 6 months later. All patients were followed for a minimum period of 6-12 months. Results: Of 51 patients, 16 were excluded (7 due to intolerance) and 35 patients entered the study, of which 83% were followed for more than 6-12 months. The average weight loss (WL) and % excess WL (%EWL) after 6 months of treatment were 11.94 kg and 42.16%, respectively. At 6-12 months, after removal of the IGB, the mean WL was 8.25 kg and %EWL was 30.27%. Nineteen patients attained a WL of ≥10% the baseline value at IGB removal and 12 maintained their weight below this threshold during the 6-12 following months. Conclusions: After temporary IGB implantation in overweight or obese individuals, a WL that was ≥10% of weight at baseline was achieved in 54.3% and sustained at 6-12 months in 41.4% of participants. IGBs are an attractive intermediate option between diet and exercise programs and bariatric surgery. In general, IGB placement is a safe and well-tolerated procedure.
- 20 January 2015
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 47 (S 01) , E534-E535
Calcium oxalate stones in a colonic surgical suture: an uncommon endoscopic finding
A 59-year old Brazilian woman had undergone ileocolonic resection in 2004 while in Brazil. She now presented to our department with abdominal pain and the passage of liquid stools (more than five daily). Her symptoms had begun 4 months earlier. She had no nausea, vomiting, or fever. The patient could not clarify the indication for her previous surgery and denied the long-term use of medications or a family history of colorectal cancer. The physical examination findings were unremarkable except for abdominal discomfort at the right iliac fossa. Colonoscopy showed, at the ileocolonic anastomosis, a surgical Prolene suture that threaded through several hard spherical structures, similar in appearance to rosary beads ([Fig. 1], [Fig. 2]). To evaluate the nature and location of the structures and the possibility of endoscopic removal, abdominal computed tomography was performed, which confirmed a colonic endoluminal location ([Fig. 3]). The suture was cut with endoscopic scissors (FS-3L-1; Olympus, Tokyo, Japan) at both entry points in the colonic wall ([Fig. 4], [Fig. 5]), and the foreign body was removed with a grasping forceps ([Fig. 6], [Video 1]). Biochemical analysis revealed that the beads were calcium oxalate stones. Prolene sutures are synthetic, nonabsorbable fiber sutures with a very smooth surface. The fibers are biologically inert and less likely than natural fibers to cause an inflammatory response [1]. Oxalate is an organic acid present in the human body and is usually found in foods. It is absorbed in the small intestine with bile acids. When calcium is taken with foods that are high in oxalates, it binds to the oxalate in the small intestine to form a compound that is not absorbed into the bloodstream and is eliminated in the stools [2]. In our patient, calcium oxalate crystals in the stool possibly adhered to the surgical suture, creating a nidus for subsequent stone growth [3]. To the best of our knowledge, this is the first case report of a foreign body reaction to a Prolene suture, with the formation of multiple calcium oxalate stones. Endoscopy_UCTN_Code_CPL_1AN_2AG
- 20 January 2015
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 47 (S 01) , E534-E535
Calcium oxalate stones in a colonic surgical suture: an uncommon endoscopic finding
A 59-year old Brazilian woman had undergone ileocolonic resection in 2004 while in Brazil. She now presented to our department with abdominal pain and the passage of liquid stools (more than five daily). Her symptoms had begun 4 months earlier. She had no nausea, vomiting, or fever. The patient could not clarify the indication for her previous surgery and denied the long-term use of medications or a family history of colorectal cancer. The physical examination findings were unremarkable except for abdominal discomfort at the right iliac fossa. Colonoscopy showed, at the ileocolonic anastomosis, a surgical Prolene suture that threaded through several hard spherical structures, similar in appearance to rosary beads ([Fig. 1], [Fig. 2]). To evaluate the nature and location of the structures and the possibility of endoscopic removal, abdominal computed tomography was performed, which confirmed a colonic endoluminal location ([Fig. 3]). The suture was cut with endoscopic scissors (FS-3L-1; Olympus, Tokyo, Japan) at both entry points in the colonic wall ([Fig. 4], [Fig. 5]), and the foreign body was removed with a grasping forceps ([Fig. 6], [Video 1]). Biochemical analysis revealed that the beads were calcium oxalate stones. Prolene sutures are synthetic, nonabsorbable fiber sutures with a very smooth surface. The fibers are biologically inert and less likely than natural fibers to cause an inflammatory response [1]. Oxalate is an organic acid present in the human body and is usually found in foods. It is absorbed in the small intestine with bile acids. When calcium is taken with foods that are high in oxalates, it binds to the oxalate in the small intestine to form a compound that is not absorbed into the bloodstream and is eliminated in the stools [2]. In our patient, calcium oxalate crystals in the stool possibly adhered to the surgical suture, creating a nidus for subsequent stone growth [3]. To the best of our knowledge, this is the first case report of a foreign body reaction to a Prolene suture, with the formation of multiple calcium oxalate stones. Endoscopy_UCTN_Code_CPL_1AN_2AG
- Open Access
- 1 December 2014
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 23 (4) , 363
Esophagitis Dissecans Superficialis Associated with Severe Clindamycin Toxicity
- 1 December 2014
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 23 (4) , 363
Open AccessEsophagitis Dissecans Superficialis Associated with Severe Clindamycin Toxicity